RADIANT-CERSI

The DigitalHealth.London RADIANT-CERSI Innovator Support Programme is designed to improve understanding of the regulatory landscape and compliance process for Software as a Medical Device (SaMD) and Artificial Intelligence as a Medical Device (AIaMD), with the goal of supporting valuable UK medical innovations to reach the market safely and efficiently.

Who is the DigitalHealth.London RADIANT-CERSI Innovator Support Programme for?

The online programme is open to up to 40 UK-based start-up companies. The start-up’s technology must be a software as a medical device (SaMD) or an artificial intelligence as a medical device (AIaMD). The technology can be of any class (I, IIa, IIb, III) but must have a technology readiness of level 4 or above.

The online programme will be delivered between Monday 16 June 2025 and Sunday 14 September 2025. Participants must be available during this period to attend nine online workshops, which will each be up to 2.5 hours in length. Companies will be expected to attend the programme in full, as this is a high-value, fully funded opportunity.

RADIANT DigitalHealth.London Innovator Support programme
Innovate UK, Medical Research Council, Office for Life Sciences, Medicines and Healthcare products Regulatory Agency, Brunel University London, Helix, Zinc, UCL, Imperial College Healthcare NHS Trust, Kings College London, HIN South London, BMJ

The DigitalHealth.London RADIANT-CERSI Innovator Support programme is delivered by DigitalHealth.London and the Health Innovation Network South London, in partnership with RADIANT-CERSI and experts in regulation.

RADIANT-CERSI is one of seven Centre of Excellence in Regulatory Science and Innovation (CERSI) in Transformative Digital Health and AI across the UK.

It is funded by Innovate UK, in partnership with the Medical Research Council, the Medicines and Healthcare Products Regulatory Agency (MHRA) and the Office for Life Sciences (OLS).

RADIANT-CERSI is led by Brunel University of London, with partners across healthcare, research and academia, including the Health Innovation Network South London, Helix Data Innovation, Zinc, UCL, Imperial College Healthcare NHS Trust, King’s College London and BMJ.

What’s involved?

Nine online workshops will support up to 40 digital health companies by:

  • Improving understanding on how to navigate current regulatory requirements for SaMD and AIaMD.   
  • Providing knowledge and guidance on how to direct the development and evaluation of digital health solutions.   
  • Offering information and practical advice on how to plan regulatory compliance activities.   
  • Facilitating opportunities to hear from peers, experts and stakeholders.       
  • Assisting with access to further resources and networking through the wider RADIANT-CERSI.